Cardiac Science to Present at Needham Biotechnology & Medical Technology Conference
BOTHELL, Wash., June 4 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced it will present at the Eighth Annual Needham & Company Biotechnology
David Kaye Launches a New Facilities Services Company to Assist the Growing Biotechnology Business in Maryland
David Kaye, President of Facilities Management Solutions, LLC has announced the start up of a facilities services company dedicated to working with the biotechnology/life sciences industry. Kaye, who has more than 40 years of experience operating, managing, maintaining, and renovating and constr...
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Arana Independent Directors Recommends Shareholders Accept the A$318 Million Offer, in the Absence of a Superior Proposal
Company Offers Strong Technology Platform and Phase II Antibody in Development for Inflammatory Diseases
FRAZER, Pa., Feb. 27 /PRNewswire-Fir...
InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
BRITISH COLUMBIA, Canada, Jan. 13 /PRNewswire-FirstCall/ -- InNexus Biotechnology
Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com ), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) tec...
Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
Attributes its 5,000 Percent Revenue Growth from FY03-FY07 to Increased CyberKnife Acceptance
SUNNYVALE, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Accuray
Incorporated (Nasdaq: ARAY ), has been named to Deloitte's Technology Fast
50 Program for Silicon Valley Scientifi...
InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
BRITISH COLUMBIA, Canada, Aug. 6 /PRNewswire-FirstCall/ -- InNexus
Biotechnology Inc., (TSX VENTURE: IXS.V; OTC Bulletin Board: IXSBF)
( http://www.ixsbio.com ), a drug development company commercializing the
next generation of monoclonal antibodies based on its Dynamic Cross Linking
Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
ROCKVILLE, Md., July 29 /PRNewswire-USNewswire/ -- Sanaria Inc., a
privately held company in Rockville, Maryland, and the University of
Institute (UMBI) announced the receipt of a
multi-year Small Business Innovation Research (SBIR) Grant from the
National Institute of A...
Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
MONTREAL, June 13 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :
HAE), a Montreal-based specialty bio-therapeutics company developing
high-value human plasma-derived protein products for commercialization,
announced today that Joseph Galli, Chairm...
CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
BRANFORD, Conn., June 6 /PRNewswire-FirstCall/ -- CuraGen Corporation
(Nasdaq: CRGN ) announced today that Dr. Timothy Shannon, President and
Chief Executive Officer, will present at The Seventh Annual Needham &
and Medical Technology Conference on Wednesday, June
NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
SAN MATEO, Calif., June 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc.
(Nasdaq: NGSX ), a biopharmaceutical company focused on developing and
commercializing novel pain management therapies, announced today that it is
scheduled to present on Thursday, June 12, 2008 at the Seventh Annual
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals,
Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing,
developing and commercializing proprietary product candidates principally
for use in the hospital setting, announced today that the company's
BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR
DALLAS, June 2 /PRNewswire/ -- BeaconEquity.com announces the
availability of TraderNotes on stocks that are making news today.
Investors can view all of the daily trading notes for free by visiting:
Today's TraderNotes include: TapImmune Inc. (OTC Bulletin ...
Genetic Engineering and Biotechnology News reports on early ADMET use
NEW ROCHELLE, NY, May 5, 2008Biotech and pharma companies are increasingly utilizing novel technologies to assess the druggability of test compounds early in the development cycle to avoid costly late clinical-stage attrition, according to Genetic Engineering and Biotechnology
News (GEN) ( http://...
China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
GUANGZHOU, China, April 21 /Xinhua-PRNewswire/ -- China Medicine
Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"),
a leading distributor and developer of ethical and over-the-counter drugs,
traditional Chinese medicines (TCM), nutritional and dietary supplements,
Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference
SOUTH SAN FRANCISCO, Calif., March 27 /PRNewswire-FirstCall/ -- Rigel
Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that Raul R.
Rodriguez, the company's executive vice president and chief operating
officer, is scheduled to present a company overview at the 8th Annual
Fortis Biotech C...
Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
New Rochelle, NY, March 18, 2008Biotechnology companies are increasingly turning to developing nations as sites for clinical trials, reports Genetic Engineering and Biotechnology
News (GEN). Increasing competition for clinical trial patients in the industrialized world is one of the major reasons ...
DuPont Strengthens Leading Biotechnology Position with Leadership Changes
Company Addressing Growing Global Demand for Biotech-Based Materials, Fuel, Food, Feed
WILMINGTON, Del., Feb. 27 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD )
today announced leadership changes to strengthen its leading biotechnology
position and better serve the gr...
Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
EAST SETAUKET, N.Y., Feb. 26 /PRNewswire-FirstCall/ -- Lixte
Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT:OB) and its
collaborator, the Surgical Neurology Branch (SNB), National Institute of
Neurological Disorders and Stroke (NINDS), National Institutes of Health
(NIH), reported at t...
NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
LAWRENCE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc.
(Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products,
today announced that Jeffrey H. Burbank, Chief Executive Officer, will
participate in the Merrill Lynch Pharmaceutical, Biotechnology
Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
PRINCETON, N.J., Jan. 31 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) announced today that it is scheduled to present at the
Merrill Lynch Global Pharmaceutical, Biotechnology
& Medical Device
Conference at 9:20 a.m. ET on Thursday, February 7, 2008. The event will be
webcast live ...
2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
CAMBRIDGE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced that its presentation
at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology
Device Conference will be webcast live and may be accessed by visiting the
Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynch's Global Pharmaceutical, Biotechnology and Medical Device Conference
DUBLIN, Ohio, Jan. 30 /PRNewswire-FirstCall/ -- Cardinal Health Chief
Executive Officer of Clinical & Medical Products, David Schlotterbeck, will
address investors at the Merrill Lynch Global Pharmaceutical, Biotechnology
and Medical Device Conference in New York on Feb. 7 at 9:20 a.m. Eastern...
Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals,
Inc. (Nasdaq: ARNA ) announced today that the company is scheduled to
present at the Merrill Lynch Global Pharmaceutical, Biotechnology
Medical Device Conference on February 5, 2008 at 9:20 a.m. Eastern Time
(6:20 a.m. Pa...
MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
MOUNTAIN VIEW, Calif., Jan. 30 /PRNewswire-FirstCall/ -- MAP
Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the company will
present at the Merrill Lynch Global Pharmaceutical, Biotechnology
Medical Device Conference on Wednesday, February 6, 2008, at 1:40 pm (ET)
in New York ...
Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
SAN CARLOS, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Nektar
Therapeutics' (Nasdaq: NKTR ) President and Chief Executive Officer, Howard
W. Robin, is scheduled to present at the upcoming Merrill Lynch
& Medical Device Conference in New York at
the Grand Hyatt New...
Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
PT. RICHMOND, Calif., Jan. 29 /PRNewswire/ -- Transcept
Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President &
Chief Executive Officer, will present at the 2008 Merrill Lynch Global
and Medical Device Conference at the Grand
Hyatt Hotel in New Y...
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
FRANKLIN LAKES, N.J., Jan. 28 /PRNewswire-FirstCall/ -- BD (Becton,
Dickinson and Company) (NYSE: BDX ), a global medical technology company,
announced today that it would present at the Merrill Lynch Global
and Medical Device Conference on Thursday,
February 7, ...
Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Council's Ninth Annual MASS Opportunities Investment Conference
Governor Patrick Asks Biotech Community for Continued Efforts on $1 Billion Life Sciences Legislation Future of Biotechnology
Featured: RNA, Nanomedicine, Mitochondria Capital Financing for Biotech Sector Could Hit New Highs for 2007 Editor's Note: Reporters can listeni...
MichBio Announces Formation of Biotechnology Legislative Caucus
ANN ARBOR, Mich., Oct. 18 /PRNewswire/ -- MichBio, the statewide trade
association for Michigan's life sciences industry, announced the formation
of a new Biotechnology
Legislative Caucus during its annual Expo &
Conference being held in Lansing Oct. 16-17. "MichBio very much looks forward to...
Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
IRVINE, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Spectrum
Pharmaceuticals, Inc., (Nasdaq: SPPI ) announced today that it will present
an overview of the Company on Wednesday, October 10, 2007, at 4:45 p.m.
Pacific, at the BIO Investor Forum, being held at the Palace Hotel in San
Opportunities to Invest in Puerto Rico as Global Center for Biotechnology
25% of world's biological manufacturing capacity is in Puerto Rico
MEXICO CITY, Feb. 12 /PRNewswire/ -- A quarter of the world's
biotechnology manufacturing capacity is located in Puerto Rico, making it
one of the largest concentrations in the world.
Over the past four years, more than $4...
Not just humans benefit from animal biotechnology
Laboratory animals are the source of major discoveries and breakthroughs in biology, not just in tackling disease but also unravelling fundamental molecular processes. Delegates at a recent research conference organised by the European Science Foundation (ESF) and Wellcome Trust heard how technolo...
Rhode Island Biotechnology Company Develops Tularemia Vaccine
EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has developed a promising tularemia vaccine // candidate (TuliVaxTM) that confers protective immunity. Francisella tularensis is a bacterium considered to be one of the most dangerous potential bioterror agents.
Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
Meria heikela, Leader of Finpro’s global industry team said that Telemedicine and biotechnology
are the two important potential areas of cooperation between Finland and India.// Ms. Heikela talked to a gathering of Industry representatives at an interaction organized by the Confederation of Indian ...
Biologicals Transfer Proposal between US and Indian Biotechnology
An agreement in principle to enable the smooth transfer of microorganisms and biological materials from the US to India is an encouraging sign for Indian bioscience. But slow implementation of the country’s broader biotech // goals, including India’s grandiose scheme to become the global hub of con...
U.S. Stem Cell Research Seems to Focus on Two Lines
...gined that we would find that three-fourths of the requests would be for the same two cell lines."
The study appears in the Aug. 7 issue of Nature biotechnology
Scott and his fellow researchers said the findings raise concerns about the reauthorization process of stem cell lines under way at the U.S. Nati...
GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
...IV-1 vaccine would be expected to significantly decrease the prevalence of AIDS over time.
About GeoVax Labs, Inc.
GeoVax Labs, Inc. is a biotechnology
company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and...
BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company
...nc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology
and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed R...
DSM Announces SafeBridge(R) Potent Compound Safety Certification
SafeBridge Consultants, Inc.
The premier occupational health and safety consulting firm to the pharmaceutical, biotechnology
and fine chemical industry with offices in Mountain View, CA, New York, NY and Liverpool, UK. SafeBridge has provided the Potent Compound Safety Tria...
Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
...vers, develops, manufactures and delivers innovative human therapeutics. A biotechnology
pioneer since 1980, Amgen was one of the first companies to realize the new...ery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology
products and non-prescription medicines that improve the quality of life fo...